Valneva (VALN) News Today $6.60 +0.03 (+0.40%) Closing price 05/5/2025 03:58 PM EasternExtended Trading$6.57 -0.03 (-0.45%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Health Secretary tours company's state-of-the-art manufacturing facility in LivingstonMay 5 at 11:23 AM | msn.comValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's What HappenedValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's What HappenedMay 5 at 4:15 AM | marketbeat.comHealth Secretary tours site of Scotland’s largest vaccine producerMay 2, 2025 | msn.comValneva (NASDAQ:VALN) Shares Down 3.6% - Here's What HappenedValneva (NASDAQ:VALN) Trading Down 3.6% - What's Next?May 1, 2025 | marketbeat.comValneva (VALN) Expected to Announce Earnings on TuesdayValneva (NASDAQ:VALN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-valneva-se-american-depositary-shares-stock/)May 1, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - What's Next?Valneva (NASDAQ:VALN) Shares Gap Down - Here's What HappenedApril 30, 2025 | marketbeat.comShort Interest in Valneva SE (NASDAQ:VALN) Drops By 49.2%Valneva SE (NASDAQ:VALN - Get Free Report) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 9,900 shares, a decrease of 49.2% from the March 31st total of 19,500 shares. Currently, 0.0% of the company's stock are short sold. Based on an average daily volume of 78,400 shares, the days-to-cover ratio is currently 0.1 days.April 29, 2025 | marketbeat.comFrance halts Valneva’s chikungunya vaccine use in seniorsApril 28, 2025 | finance.yahoo.comValneva Shares Slump After France Suspends Chikungunya Vaccine for ElderlyApril 28, 2025 | marketwatch.comIn a world first, Brazil approves chikungunya vaccineApril 28, 2025 | msn.comValneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French AuthoritiesApril 26, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 25, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?Valneva (NASDAQ:VALN) Shares Gap Up - Time to Buy?April 24, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 22, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 21, 2025 | globenewswire.comValneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. TravelersApril 18, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 17, 2025 | gurufocus.comValneva (NASDAQ:VALN) Receives "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $17.00 price objective on shares of Valneva in a research note on Tuesday.April 17, 2025 | marketbeat.comValneva (NASDAQ:VALN) Trading 11.1% Higher - Here's WhyValneva (NASDAQ:VALN) Trading Up 11.1% - Should You Buy?April 16, 2025 | marketbeat.comValneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®April 16, 2025 | globenewswire.comValneva granted marketing authorization for Ixchiq in BrailApril 16, 2025 | markets.businessinsider.comValneva SE: Initiating Hold Rating Based On Potentially Limited UpsideApril 16, 2025 | seekingalpha.com1VALN : 12 Analysts Assess Valneva: What You Need To KnowApril 15, 2025 | benzinga.comValneva shares leap on Brazilian approval of chikungunya vaccineApril 14, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 14, 2025 | prnewswire.comMajor West Lothian employer invests in its emerging leadersApril 14, 2025 | msn.comBrazil Approves Valneva's Mosquito-Borne Chikungunya VaccineApril 14, 2025 | benzinga.comValneva’s Chikungunya Vaccine Gains First Approval in BrazilApril 14, 2025 | tipranks.comValneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic CountryApril 14, 2025 | globenewswire.comMajor Livingston employer invests in its emerging leadersApril 14, 2025 | msn.comValneva (NASDAQ:VALN) Sees Strong Trading Volume - Here's What HappenedValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - What's Next?April 11, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Valneva (NASDAQ:VALN)HC Wainwright reissued a "buy" rating and issued a $17.00 target price on shares of Valneva in a research report on Wednesday.April 11, 2025 | marketbeat.comValneva (NASDAQ:VALN) Trading Up 6.2% - Here's WhyValneva (NASDAQ:VALN) Stock Price Up 6.2% - What's Next?April 9, 2025 | marketbeat.comValneva and LimmaTech Initiate Phase 2 Study of Shigella VaccineApril 9, 2025 | tipranks.comValneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2April 9, 2025 | globenewswire.comValneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2April 9, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 8, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNApril 7, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 7, 2025 | globenewswire.comVALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law FirmApril 7, 2025 | prnewswire.comVALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law FirmApril 4, 2025 | businesswire.comValneva SE Shareholding Declaration - March 2025April 3, 2025 | finance.yahoo.comValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedApril 2, 2025 | marketbeat.comValneva granted EC marketing authorization for Ixchiq vaccineApril 2, 2025 | markets.businessinsider.comValneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and AboveApril 2, 2025 | markets.businessinsider.comIs Valneva (VALN) the Best Performing NASDAQ Stock So Far in 2025?April 2, 2025 | msn.comValneva’s Chikungunya Vaccine Gains EU Approval for AdolescentsApril 1, 2025 | tipranks.comHC Wainwright Reiterates "Buy" Rating for Valneva (NASDAQ:VALN)HC Wainwright reiterated a "buy" rating and issued a $17.00 target price on shares of Valneva in a research report on Monday.April 1, 2025 | marketbeat.comValneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and AboveApril 1, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 31, 2025 | prnewswire.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.260.72▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼65▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KYMR News CGON News MTSR News MIRM News BHC News BEAM News NAMS News VCEL News BLTE News TARS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VALN Stock Free VALN Stock Alerts